Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

1.98
-0.0900-4.35%
Post-market: 1.980.00000.00%16:05 EDT
Volume:2.21M
Turnover:4.42M
Market Cap:285.04M
PE:-1.89
High:2.10
Open:2.09
Low:1.96
Close:2.07
Loading ...
Sep 07, 2021

Public Prospectus

MARAVAI LIFESCIENCES HOLDINGS, INC.
Sep 07, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Sep 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 03, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 05, 2021

Major Issues Report

8-K - Current report
Apr 05, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 22, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals